Abstract
Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have